Literature DB >> 14559775

Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.

Nilüfer Ertekin-Taner1, James Ronald, Hideaki Asahara, Linda Younkin, Maria Hella, Shushant Jain, Eugene Gnida, Samuel Younkin, Daniel Fadale, Yasumasa Ohyagi, Adam Singleton, Leah Scanlin, Mariza de Andrade, Ronald Petersen, Neill Graff-Radford, Michael Hutton, Steven Younkin.   

Abstract

Using plasma amyloid beta protein (Abeta42) levels as an intermediate, quantitative phenotype for late onset Alzheimer's disease (LOAD), we previously obtained significant linkage at approximately 80 cM on chromosome 10. Linkage to the same region was obtained independently in a study of affected LOAD sib-pairs. Together, these two studies provide strong evidence for a novel LOAD locus on chromosome 10 that acts to increase Abeta42. VR22 is a large (1.7 Mb) gene located at 80 cM that encodes alpha-T catenin, which is a binding partner of beta catenin. This makes VR22 an attractive candidate gene because beta catenin interacts with presenilin 1, which has many mutations that elevate Abeta42 and cause early onset familial AD. We identified two intronic VR22 SNPs (4360 and 4783) in strong linkage disequilibrium (LD) that showed highly significant association (P=0.0001 and 0.0006) with plasma Abeta42 in 10 extended LOAD families. This association clearly contributed to the linkage at approximately 80 cM because the lod scores decreased when linkage analysis was performed conditional upon the VR22 association. This association replicated in another independent set of 12 LOAD families (P=0.04 for 4783 and P=0.08 for 4360). Bounding of the association region using multiple SNPs showed VR22 to be the only confirmed gene within the region of association. These findings indicate that VR22 has variant(s) which influence Abeta42 and contribute to the previously reported linkage for plasma Abeta42 in LOAD families.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559775      PMCID: PMC2836540          DOI: 10.1093/hmg/ddg343

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  57 in total

1.  Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21.

Authors:  N Patil; A J Berno; D A Hinds; W A Barrett; J M Doshi; C R Hacker; C R Kautzer; D H Lee; C Marjoribanks; D P McDonough; B T Nguyen; M C Norris; J B Sheehan; N Shen; D Stern; R P Stokowski; D J Thomas; M O Trulson; K R Vyas; K A Frazer; S P Fodor; D R Cox
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

2.  Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease.

Authors:  J D Rioux; M J Daly; M S Silverberg; K Lindblad; H Steinhart; Z Cohen; T Delmonte; K Kocher; K Miller; S Guschwan; E J Kulbokas; S O'Leary; E Winchester; K Dewar; T Green; V Stone; C Chow; A Cohen; D Langelier; G Lapointe; D Gaudet; J Faith; N Branco; S B Bull; R S McLeod; A M Griffiths; A Bitton; G R Greenberg; E S Lander; K A Siminovitch; T J Hudson
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

3.  Multipoint estimation of identity-by-descent probabilities at arbitrary positions among marker loci on general pedigrees.

Authors:  E Sobel; H Sengul; D E Weeks
Journal:  Hum Hered       Date:  2001       Impact factor: 0.444

4.  High-resolution haplotype structure in the human genome.

Authors:  M J Daly; J D Rioux; S F Schaffner; T J Hudson; E S Lander
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

5.  Heritability of plasma amyloid beta in typical late-onset Alzheimer's disease pedigrees.

Authors:  N Ertekin-Taner; N Graff-Radford; L H Younkin; C Eckman; J Adamson; D J Schaid; J Blangero; M Hutton; S G Younkin
Journal:  Genet Epidemiol       Date:  2001-07       Impact factor: 2.135

6.  A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease.

Authors:  José Manuel Soria; Laura Almasy; Juan Carlos Souto; Delphine Bacq; Alfonso Buil; Alexandra Faure; Elisabeth Martínez-Marchán; José Mateo; Montserrat Borrell; William Stone; Mark Lathrop; Jordi Fontcuberta; John Blangero
Journal:  Am J Hum Genet       Date:  2002-01-22       Impact factor: 11.025

Review 7.  The genetics of Alzheimer's disease.

Authors:  G D Schellenberg; I D'Souza; P Poorkaj
Journal:  Curr Psychiatry Rep       Date:  2000-04       Impact factor: 5.285

8.  Susceptibility locus for Alzheimer's disease on chromosome 10.

Authors:  A Myers; P Holmans; H Marshall; J Kwon; D Meyer; D Ramic; S Shears; J Booth; F W DeVrieze; R Crook; M Hamshere; R Abraham; N Tunstall; F Rice; S Carty; S Lillystone; P Kehoe; V Rudrasingham; L Jones; S Lovestone; J Perez-Tur; J Williams; M J Owen; J Hardy; A M Goate
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

9.  Age at onset in two common neurodegenerative diseases is genetically controlled.

Authors:  Yi-Ju Li; William K Scott; Dale J Hedges; Fengyu Zhang; P Craig Gaskell; Martha A Nance; Ray L Watts; Jean P Hubble; William C Koller; Rajesh Pahwa; Matthew B Stern; Bradley C Hiner; Joseph Jankovic; Fred A Allen; Christopher G Goetz; Frank Mastaglia; Jeffrey M Stajich; Rachel A Gibson; Lefkos T Middleton; Ann M Saunders; Burton L Scott; Gary W Small; Kristin K Nicodemus; Allison D Reed; Donald E Schmechel; Kathleen A Welsh-Bohmer; P Michael Conneally; Allen D Roses; John R Gilbert; Jeffery M Vance; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

10.  alphaT-catenin: a novel tissue-specific beta-catenin-binding protein mediating strong cell-cell adhesion.

Authors:  B Janssens; S Goossens; K Staes; B Gilbert; J van Hengel; C Colpaert; E Bruyneel; M Mareel; F van Roy
Journal:  J Cell Sci       Date:  2001-09       Impact factor: 5.285

View more
  28 in total

Review 1.  Neurogenetics II: complex disorders.

Authors:  A F Wright
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

2.  Novel genes identified in a high-density genome wide association study for nicotine dependence.

Authors:  Laura Jean Bierut; Pamela A F Madden; Naomi Breslau; Eric O Johnson; Dorothy Hatsukami; Ovide F Pomerleau; Gary E Swan; Joni Rutter; Sarah Bertelsen; Louis Fox; Douglas Fugman; Alison M Goate; Anthony L Hinrichs; Karel Konvicka; Nicholas G Martin; Grant W Montgomery; Nancy L Saccone; Scott F Saccone; Jen C Wang; Gary A Chase; John P Rice; Dennis G Ballinger
Journal:  Hum Mol Genet       Date:  2006-12-07       Impact factor: 6.150

3.  Is alpha-T catenin (VR22) an Alzheimer's disease risk gene?

Authors:  Lars Bertram; Kristina Mullin; Michele Parkinson; Monica Hsiao; Thomas J Moscarillo; Steven L Wagner; K David Becker; Gonul Velicelebi; Deborah Blacker; Rudolph E Tanzi
Journal:  J Med Genet       Date:  2007-01       Impact factor: 6.318

4.  Towards compendia of negative genetic association studies: an example for Alzheimer disease.

Authors:  Mia E-L Blomqvist; Chandra Reynolds; Hagit Katzov; Lars Feuk; Niels Andreasen; Nenad Bogdanovic; Kaj Blennow; Anthony J Brookes; Jonathan A Prince
Journal:  Hum Genet       Date:  2005-12-08       Impact factor: 4.132

5.  Parsing the genetic heterogeneity of chromosome 12q susceptibility genes for Alzheimer disease by family-based association analysis.

Authors:  Ping-I Lin; Eden R Martin; Carrie A Browning-Large; Donald E Schmechel; Kathleen A Welsh-Bohmer; P Murali Doraiswamy; John R Gilbert; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Neurogenetics       Date:  2006-06-13       Impact factor: 2.660

6.  Effect of genetic variation in LRRTM3 on risk of Alzheimer disease.

Authors:  Christiane Reitz; Christopher Conrad; Katherine Roszkowski; Robert S Rogers; Richard Mayeux
Journal:  Arch Neurol       Date:  2012-07

7.  Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease.

Authors:  Victoria Busby; Steven Goossens; Petra Nowotny; Gillian Hamilton; Scott Smemo; Denise Harold; Dragana Turic; Luke Jehu; Amanda Myers; Meredith Womick; Daniel Woo; Danielle Compton; Lisa M Doil; Kristina M Tacey; Kit F Lau; Safa Al-Saraj; Richard Killick; Stuart Pickering-Brown; Pamela Moore; Paul Hollingworth; Nicola Archer; Catherine Foy; Sarah Walter; Corrine Lendon; Takeshi Iwatsubo; John C Morris; Joanne Norton; David Mann; Barbara Janssens; John Hardy; Michael O'Donovan; Lesley Jones; Julie Williams; Peter Holmans; Michael J Owen; Andrew Grupe; John Powell; Jolanda van Hengel; Alison Goate; Frans Van Roy; Simon Lovestone
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

8.  Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.

Authors:  J H Lee; R Mayeux; D Mayo; J Mo; V Santana; J Williamson; A Flaquer; A Ciappa; H Rondon; P Estevez; R Lantigua; T Kawarai; A Toulina; M Medrano; M Torres; Y Stern; B Tycko; E Rogaeva; P St George-Hyslop; J A Knowles
Journal:  Mol Psychiatry       Date:  2004-11       Impact factor: 15.992

9.  Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts.

Authors:  Jiao Li; Xiaoyan Zhu; Jake Yue Chen
Journal:  PLoS Comput Biol       Date:  2009-07-31       Impact factor: 4.475

10.  Confronting complexity in late-onset Alzheimer disease: application of two-stage analysis approach addressing heterogeneity and epistasis.

Authors:  Tricia A Thornton-Wells; Jason H Moore; Eden R Martin; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Genet Epidemiol       Date:  2008-04       Impact factor: 2.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.